Linklaters‘ antitrust and foreign investment group excels at advising its varied client base on complex merger controls and providing expertise on investigations and litigation. The team uses its expansive knowledge to provide advice in sectors such as technology, healthcare, and automotive industries. Clients include large multinationals and Chinese state-owned enterprises. Beijing-based Fay Zhou heads up the team specialising in competition law and regulatory issues for both multinational and local clients. She uses her experience at China’s Ministry of Commerce to assist with regulatory issues and often acts as an advisor to Chinese authorities, ensuring her team has a strong relationship with SAMR. The firm runs a joint operation with Zhao Sheng Law Firm where co-heads Xi Liao and Arthur Peng work as part of an integrated team. Qiuying Zheng and Larry Zhou both handle high-profile cases of merger control/compliance, investigations and regulatory issues.
Testimonials
Collated independently by Legal 500 research team.
‘Fay Zhou and her team have been deeply involved in the field of China's anti-monopoly law for many years, participated in legal discussions, represented many clients in antimonopoly investigations, and assisted clients in establishing antimonopoly compliance systems. Her knowledge of monopoly legal rules is rare in a lawyer.’
‘Fay Zhou is an outstanding professional. She has clear communication with her customers, is timely and completes her work well.’
Key clients
- Ams
- AstraZeneca
Work highlights
- Advising Microsoft on the Chinese merger filing for its US$70 billion acquisition of Activision Blizzard.
- Advising Intel on China regulatory aspects of its $5.4bn acquisition of Tower Semiconductors.